AI-generated summary
The authors report a randomized trial of 60 participants with recurrent herpes labialis comparing acyclovir cream with a laser, laser alone, and methylene blue photodynamic therapy combined with laser. The combined group reported lower pain than the control group at several time points and healed faster, and the authors describe the approach as promising.
- Participants
- 60
- Who or what was studied
- Participants with recurrent herpes labialis
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract does not describe blinding, the size of the between-group differences, or long-term follow-up, so the certainty of the findings is limited.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
- Power
- 100 mW, 0.1 W
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photodynamic therapy, Photobiomodulation, Laser, Randomized controlled trial, Low-level laser therapy, Wavelength, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.